Abstract:<section class="article-section__content"><h3 class="article-section__sub-title section1"> Background</h3><p>(2<i>R</i>,3<i>S</i>)‐<i>N</i>‐tert‐Butoxycarbonyl‐3‐amino‐1‐chloro‐2‐hydroxy‐4‐phenylbutane (1b) is key for the synthesis of the antiviral drug atazanavir. It can be obtained via the stereoselective bioreduction of (3<i>S</i>)‐3‐(<i>N</i>‐Boc‐amino)‐1‐chloro‐4‐phenyl‐butanone (1a) with short‐chain dehydrogenase/reductase (SDR)(EC 1.1.1.1). To develop a practical and cost‐effective biocatalytic approach with high stability and reusability, an SDR mutant (muSDR) from <i>Novosphingobium aromaticivorans</i> was overexpressed in <i>Escherichia coli</i> cell and immobilized by cross‐linked enzyme aggregates with enhanced stability and high efficiency. </p></section><section class="article-section__content"><h3 class="article-section__sub-title section1"> Results</h3><p>muSDR gene was successfully cloned and overexpressed in <i>Escherichia coli</i> and reduced 1a to 1b with high stereoselectivity. Four resin‐bound muSDR and cross‐linked muSDR aggregates (muSDR‐CLEAs) were prepared and compared. With addition of Tween‐80, the muSDR‐CLEAs demonstrated much higher activity recovery than resin‐bound muSDR. Compared with free enzyme, muSDR‐CLEAs demonstrated enhanced thermal, pH, and storage stabilities and could obtain 1b with high substrate concentration, high <i>de</i>, and complete conversion. The reusability of CLEAs was also determined as no significant activity loss was observed after seven batches of reactions. The space time yield of the bioreduction using muSDR‐CLEAs was 226.6 g∙L<sup>‐1</sup>∙d<sup>‐1</sup>. </p></section><section class="article-section__content"><h3 class="article-section__sub-title section1"> Conclusion</h3><p>Overexpressed muSDR was efficiently immobilized, and it demonstrated superior stability and reusability. The recombinant muSDR and muSDR‐CLEAs are practical potential biocatalysts for industrial production of the atazanavir precursor.</p><p>This article is protected by copyright. All rights reserved.</p></section>

Streamlined Chemo-Enzymatic Synthesis of Molnupiravir via Lipase Catalyst

Expedient Synthesis of Antiviral Drug Molnupiravir from D-Ribose and Cytosine

“One-Pot” Synthesis of Molnupiravir from Cytidine

Use of Lipase Catalytic Resolution in the Preparation of Ethyl (2S,5r)-5-((benzyloxy)amino)piperidine-2-carboxylate, a Key Intermediate of the Β-Lactamase Inhibitor Avibactam

Scaling the Process Chemistry of a COVID-19 Antiviral Pharmaceutical Down for a Multistep Synthesis Experiment in the Undergraduate Teaching Laboratory

Chemoenzymatic Synthesis of Tenofovir

Chemo-Enzymatic Synthesis of Valrubicin Using Pluronic Conjugated Lipase with Temperature Responsiveness in Organic Media

Continuous flow biocatalysis: synthesis of purine nucleoside esters catalyzed by lipase TL IM from Thermomyces lanuginosus

Cloning and Characterization of Purine Nucleoside Phosphorylase in Escherichia Coli and Subsequent Ribavirin Biosynthesis Using Immobilized Recombinant Cells

Mechanochemical enzymatic synthesis of 1,4‐dihydropyridine calcium antagonists and derivatives

Enzymatic synthesis of phosphocarnitine, phosphogabob and fosfomycin.

An Efficient Synthesis of the Bicyclic Darunavir Side Chain Using Chemoenzymatic Catalysis

One-pot method of recyclable lipase-nanocatalyst based on chitosan magnetic nanomaterial for ethyl levulinate synthesis

Sustainable Flow‐Synthesis of (Bulky) Nucleoside Drugs by a Novel and Highly Stable Nucleoside Phosphorylase Immobilized on Reusable Supports

Catalytic Regioselective Acylation of Unprotected Nucleosides for Quick Access to COVID and Other Nucleoside Prodrugs

Design of an in vitro biocatalytic cascade for the manufacture of islatravir

Process Development of a Novel Route to Rilpivirine Hydrochloride

Direct and Catalytic C-Glycosylation of Arenes: Expeditious Synthesis of the Remdesivir Nucleoside

Production of Modified Nucleosides in a Continuous Enzyme Membrane Reactor

Controllable Regioselective Enzymatic Synthesis of Polymerizable 5′-O-vinyl- and 3′-O-vinyl-nucleoside Analogues in Acetone

Efficient synthesis of an antiviral drug intermediate using overexpressed short‐chain dehydrogenase and cross‐linked enzyme aggregates stabilization